Subscribe to RSS Feed
Medicines-Diabetes Treatment-Gomeopharm-Medice-Ipsen-EndoPharm-Haupt Pharma-NovoNordisk-Valenta-Zentiva-Dr.Reddy's-Shering-Plau-Belupo-KRKA-Madaus-Medisorb-Sandoz-Kamelia-Vifor-Nanjing-Italfarmaco-Falk Pharma-SUNpharma-UPSA-Biocodex-Dompe-Hyperion-Hexal-Avexima-Allergan-Фармстандарт-Лексредства ОАО
Ozempic® (Semavik) 0,25/0,5/1 mg/dose solution for subcutaneous administration 3 ml syringe pen 1 pc.
Ozempic is a self-injectable medication that contains the active ingredient, semaglutide. Previously, it has been prescribed ‘off label’ for weight loss, but it is licensed in the UK for treating type 2 diabetes. Semaglutide is available as a weight loss injection under the brand name Semavik.
Medicines-Diabetes Treatment-Gomeopharm-Medice-Ipsen-EndoPharm-Haupt Pharma-NovoNordisk-Valenta-Zentiva-Dr.Reddy's-Shering-Plau-Belupo-KRKA-Madaus-Medisorb-Sandoz-Kamelia-Vifor-Nanjing-Italfarmaco-Falk Pharma-SUNpharma-UPSA-Biocodex-Dompe-Hyperion-Hexal-Avexima-Allergan-Фармстандарт-Лексредства ОАО
Currently Shopping by
- The purpose of the medication: Remove This Item Diabetes Treatment
-
Manufacturer:
Gomeopharm
Medice
Ipsen
EndoPharm
Haupt Pharma
NovoNordisk
Valenta
Zentiva
Dr.Reddy's
Shering-Plau
Belupo
KRKA
Madaus
Medisorb
Sandoz
Kamelia
Vifor
Nanjing
Italfarmaco
Falk Pharma
SUNpharma
UPSA
Biocodex
Dompe
Hyperion
Hexal
Avexima
Allergan
OTCPharm JSC
- The purpose of the medication
- Manufacturer
